nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—Medroxyprogesterone Acetate—uterine cancer	0.186	0.534	CrCtD
Spironolactone—Progesterone—uterine cancer	0.162	0.466	CrCtD
Spironolactone—PGR—uterine cancer	0.131	1	CbGaD
Spironolactone—NR3C2—Progesterone—uterine cancer	0.0312	0.14	CbGbCtD
Spironolactone—PGR—Medroxyprogesterone Acetate—uterine cancer	0.0304	0.137	CbGbCtD
Spironolactone—SHBG—Medroxyprogesterone Acetate—uterine cancer	0.0292	0.131	CbGbCtD
Spironolactone—AR—Medroxyprogesterone Acetate—uterine cancer	0.0244	0.11	CbGbCtD
Spironolactone—PGR—Progesterone—uterine cancer	0.0202	0.0905	CbGbCtD
Spironolactone—SHBG—Progesterone—uterine cancer	0.0193	0.0868	CbGbCtD
Spironolactone—AR—Progesterone—uterine cancer	0.0162	0.0726	CbGbCtD
Spironolactone—NR3C1—Medroxyprogesterone Acetate—uterine cancer	0.0155	0.0698	CbGbCtD
Spironolactone—Eplerenone—Medroxyprogesterone Acetate—uterine cancer	0.0138	0.0593	CrCrCtD
Spironolactone—Eplerenone—Progesterone—uterine cancer	0.012	0.0517	CrCrCtD
Spironolactone—Oxandrolone—Progesterone—uterine cancer	0.0113	0.0485	CrCrCtD
Spironolactone—Drospirenone—Medroxyprogesterone Acetate—uterine cancer	0.011	0.0471	CrCrCtD
Spironolactone—Dydrogesterone—Medroxyprogesterone Acetate—uterine cancer	0.011	0.0471	CrCrCtD
Spironolactone—Potassium Canrenoate—Medroxyprogesterone Acetate—uterine cancer	0.0104	0.0449	CrCrCtD
Spironolactone—NR3C1—Progesterone—uterine cancer	0.0103	0.0462	CbGbCtD
Spironolactone—Drospirenone—Progesterone—uterine cancer	0.00956	0.0411	CrCrCtD
Spironolactone—Dydrogesterone—Progesterone—uterine cancer	0.00956	0.0411	CrCrCtD
Spironolactone—Megestrol acetate—Medroxyprogesterone Acetate—uterine cancer	0.00956	0.0411	CrCrCtD
Spironolactone—Potassium Canrenoate—Progesterone—uterine cancer	0.00911	0.0391	CrCrCtD
Spironolactone—Megestrol acetate—Progesterone—uterine cancer	0.00833	0.0358	CrCrCtD
Spironolactone—Hydrocortamate—Medroxyprogesterone Acetate—uterine cancer	0.00767	0.033	CrCrCtD
Spironolactone—Cortisone acetate—Medroxyprogesterone Acetate—uterine cancer	0.00744	0.0319	CrCrCtD
Spironolactone—Medroxyprogesterone Acetate—Progesterone—uterine cancer	0.00741	0.0318	CrCrCtD
Spironolactone—Hydrocortamate—Progesterone—uterine cancer	0.00669	0.0287	CrCrCtD
Spironolactone—Fluoxymesterone—Medroxyprogesterone Acetate—uterine cancer	0.00663	0.0285	CrCrCtD
Spironolactone—Cortisone acetate—Progesterone—uterine cancer	0.00648	0.0278	CrCrCtD
Spironolactone—Fludrocortisone—Medroxyprogesterone Acetate—uterine cancer	0.00646	0.0277	CrCrCtD
Spironolactone—Testosterone Propionate—Medroxyprogesterone Acetate—uterine cancer	0.00646	0.0277	CrCrCtD
Spironolactone—Progesterone—Medroxyprogesterone Acetate—uterine cancer	0.00646	0.0277	CrCrCtD
Spironolactone—Methyltestosterone—Medroxyprogesterone Acetate—uterine cancer	0.0063	0.0271	CrCrCtD
Spironolactone—Testolactone—Progesterone—uterine cancer	0.00629	0.027	CrCrCtD
Spironolactone—Fluoxymesterone—Progesterone—uterine cancer	0.00578	0.0248	CrCrCtD
Spironolactone—Testosterone Propionate—Progesterone—uterine cancer	0.00563	0.0242	CrCrCtD
Spironolactone—Fludrocortisone—Progesterone—uterine cancer	0.00563	0.0242	CrCrCtD
Spironolactone—Testosterone—Medroxyprogesterone Acetate—uterine cancer	0.00561	0.0241	CrCrCtD
Spironolactone—Methyltestosterone—Progesterone—uterine cancer	0.00549	0.0236	CrCrCtD
Spironolactone—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.00535	0.024	CbGbCtD
Spironolactone—Hydrocortisone—Medroxyprogesterone Acetate—uterine cancer	0.00527	0.0226	CrCrCtD
Spironolactone—Testosterone—Progesterone—uterine cancer	0.00489	0.021	CrCrCtD
Spironolactone—Hydrocortisone—Progesterone—uterine cancer	0.00459	0.0197	CrCrCtD
Spironolactone—ABCC2—Carboplatin—uterine cancer	0.00392	0.0176	CbGbCtD
Spironolactone—CYP2C8—Progesterone—uterine cancer	0.00354	0.0159	CbGbCtD
Spironolactone—ABCC2—Etoposide—uterine cancer	0.00329	0.0148	CbGbCtD
Spironolactone—Benign breast neoplasm—Medroxyprogesterone Acetate—uterine cancer	0.00293	0.116	CcSEcCtD
Spironolactone—PGR—corpus luteum—uterine cancer	0.00266	0.141	CbGeAlD
Spironolactone—Carcinoma breast—Progesterone—uterine cancer	0.00251	0.0992	CcSEcCtD
Spironolactone—ABCB1—Progesterone—uterine cancer	0.0024	0.0108	CbGbCtD
Spironolactone—ABCC2—Doxorubicin—uterine cancer	0.00224	0.0101	CbGbCtD
Spironolactone—ABCB1—Dactinomycin—uterine cancer	0.0019	0.00853	CbGbCtD
Spironolactone—CYP2C8—Etoposide—uterine cancer	0.00158	0.00711	CbGbCtD
Spironolactone—SHBG—semen—uterine cancer	0.00138	0.0735	CbGeAlD
Spironolactone—ABCB1—Etoposide—uterine cancer	0.00107	0.00482	CbGbCtD
Spironolactone—AR—semen—uterine cancer	0.000993	0.0527	CbGeAlD
Spironolactone—Breast cancer—Progesterone—uterine cancer	0.00093	0.0368	CcSEcCtD
Spironolactone—PGR—oviduct—uterine cancer	0.000914	0.0486	CbGeAlD
Spironolactone—Breast cancer—Medroxyprogesterone Acetate—uterine cancer	0.000843	0.0333	CcSEcCtD
Spironolactone—ABCB1—Doxorubicin—uterine cancer	0.000732	0.00328	CbGbCtD
Spironolactone—AR—oviduct—uterine cancer	0.000728	0.0387	CbGeAlD
Spironolactone—Menstruation irregular—Progesterone—uterine cancer	0.000613	0.0242	CcSEcCtD
Spironolactone—PGR—artery—uterine cancer	0.000605	0.0322	CbGeAlD
Spironolactone—Menstruation irregular—Medroxyprogesterone Acetate—uterine cancer	0.000555	0.022	CcSEcCtD
Spironolactone—Breast enlargement—Progesterone—uterine cancer	0.000523	0.0207	CcSEcCtD
Spironolactone—CYP11B2—renal system—uterine cancer	0.000519	0.0276	CbGeAlD
Spironolactone—Breast pain—Progesterone—uterine cancer	0.000389	0.0154	CcSEcCtD
Spironolactone—Amenorrhoea—Progesterone—uterine cancer	0.000386	0.0153	CcSEcCtD
Spironolactone—Breast pain—Medroxyprogesterone Acetate—uterine cancer	0.000352	0.0139	CcSEcCtD
Spironolactone—Amenorrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00035	0.0138	CcSEcCtD
Spironolactone—Ulcer—Medroxyprogesterone Acetate—uterine cancer	0.000325	0.0129	CcSEcCtD
Spironolactone—NR3C2—myometrium—uterine cancer	0.000315	0.0167	CbGeAlD
Spironolactone—Cramps of lower extremities—Progesterone—uterine cancer	0.000312	0.0123	CcSEcCtD
Spironolactone—Hyperkalaemia—Medroxyprogesterone Acetate—uterine cancer	0.000302	0.0119	CcSEcCtD
Spironolactone—PGR—myometrium—uterine cancer	0.000292	0.0155	CbGeAlD
Spironolactone—Cramps of lower extremities—Medroxyprogesterone Acetate—uterine cancer	0.000282	0.0112	CcSEcCtD
Spironolactone—Dydrogesterone—PGR—uterine cancer	0.00027	0.197	CrCbGaD
Spironolactone—Ulcer—Dactinomycin—uterine cancer	0.000254	0.01	CcSEcCtD
Spironolactone—NR3C2—uterine cervix—uterine cancer	0.000245	0.013	CbGeAlD
Spironolactone—CYP11B2—lymph node—uterine cancer	0.000243	0.0129	CbGeAlD
Spironolactone—NR3C2—smooth muscle tissue—uterine cancer	0.000238	0.0126	CbGeAlD
Spironolactone—AR—myometrium—uterine cancer	0.000233	0.0124	CbGeAlD
Spironolactone—PGR—epithelium—uterine cancer	0.00023	0.0122	CbGeAlD
Spironolactone—NR3C2—renal system—uterine cancer	0.000229	0.0122	CbGeAlD
Spironolactone—SHBG—endometrium—uterine cancer	0.000228	0.0121	CbGeAlD
Spironolactone—PGR—uterine cervix—uterine cancer	0.000228	0.0121	CbGeAlD
Spironolactone—Cramp muscle—Progesterone—uterine cancer	0.000222	0.00877	CcSEcCtD
Spironolactone—NR3C2—endometrium—uterine cancer	0.000221	0.0118	CbGeAlD
Spironolactone—PGR—smooth muscle tissue—uterine cancer	0.000221	0.0117	CbGeAlD
Spironolactone—Gastritis—Progesterone—uterine cancer	0.000218	0.00862	CcSEcCtD
Spironolactone—PGR—decidua—uterine cancer	0.000217	0.0115	CbGeAlD
Spironolactone—NR3C2—mammalian vulva—uterine cancer	0.000214	0.0114	CbGeAlD
Spironolactone—SHBG—uterus—uterine cancer	0.000211	0.0112	CbGeAlD
Spironolactone—Ataxia—Medroxyprogesterone Acetate—uterine cancer	0.00021	0.0083	CcSEcCtD
Spironolactone—PGR—endometrium—uterine cancer	0.000206	0.0109	CbGeAlD
Spironolactone—NR3C2—uterus—uterine cancer	0.000204	0.0108	CbGeAlD
Spironolactone—Cramp muscle—Medroxyprogesterone Acetate—uterine cancer	0.000201	0.00795	CcSEcCtD
Spironolactone—SLCO1A2—renal system—uterine cancer	0.000196	0.0104	CbGeAlD
Spironolactone—Drowsiness—Progesterone—uterine cancer	0.00019	0.00751	CcSEcCtD
Spironolactone—PGR—uterus—uterine cancer	0.00019	0.0101	CbGeAlD
Spironolactone—SHBG—female reproductive system—uterine cancer	0.000189	0.0101	CbGeAlD
Spironolactone—Ulcer—Etoposide—uterine cancer	0.000184	0.00726	CcSEcCtD
Spironolactone—NR3C2—female reproductive system—uterine cancer	0.000183	0.00974	CbGeAlD
Spironolactone—ABCC2—renal system—uterine cancer	0.000183	0.00972	CbGeAlD
Spironolactone—AR—epithelium—uterine cancer	0.000183	0.00972	CbGeAlD
Spironolactone—Body temperature increased—Carboplatin—uterine cancer	0.000182	0.00721	CcSEcCtD
Spironolactone—AR—uterine cervix—uterine cancer	0.000181	0.00963	CbGeAlD
Spironolactone—Lethargy—Dactinomycin—uterine cancer	0.000178	0.00703	CcSEcCtD
Spironolactone—AR—smooth muscle tissue—uterine cancer	0.000176	0.00936	CbGeAlD
Spironolactone—AR—decidua—uterine cancer	0.000173	0.00918	CbGeAlD
Spironolactone—SHBG—female gonad—uterine cancer	0.000172	0.00915	CbGeAlD
Spironolactone—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.000172	0.0068	CcSEcCtD
Spironolactone—SHBG—vagina—uterine cancer	0.000171	0.00909	CbGeAlD
Spironolactone—PGR—female reproductive system—uterine cancer	0.000171	0.00906	CbGeAlD
Spironolactone—Medroxyprogesterone Acetate—AKR1C3—uterine cancer	0.00017	0.124	CrCbGaD
Spironolactone—AR—renal system—uterine cancer	0.00017	0.00901	CbGeAlD
Spironolactone—NR3C1—myometrium—uterine cancer	0.000169	0.00896	CbGeAlD
Spironolactone—NR3C2—female gonad—uterine cancer	0.000167	0.00887	CbGeAlD
Spironolactone—NR3C2—vagina—uterine cancer	0.000166	0.00881	CbGeAlD
Spironolactone—AR—endometrium—uterine cancer	0.000164	0.00871	CbGeAlD
Spironolactone—Megestrol acetate—PGR—uterine cancer	0.000162	0.118	CrCbGaD
Spironolactone—Erythema multiforme—Progesterone—uterine cancer	0.000161	0.00637	CcSEcCtD
Spironolactone—AR—mammalian vulva—uterine cancer	0.000159	0.00843	CbGeAlD
Spironolactone—Toxic epidermal necrolysis—Dactinomycin—uterine cancer	0.000157	0.0062	CcSEcCtD
Spironolactone—PGR—female gonad—uterine cancer	0.000155	0.00824	CbGeAlD
Spironolactone—PGR—vagina—uterine cancer	0.000154	0.00819	CbGeAlD
Spironolactone—AR—uterus—uterine cancer	0.000151	0.00803	CbGeAlD
Spironolactone—Alopecia—Progesterone—uterine cancer	0.000151	0.00596	CcSEcCtD
Spironolactone—Testolactone—CYP19A1—uterine cancer	0.00015	0.109	CrCbGaD
Spironolactone—ABCC2—female reproductive system—uterine cancer	0.000146	0.00778	CbGeAlD
Spironolactone—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.000146	0.00577	CcSEcCtD
Spironolactone—Muscle spasms—Progesterone—uterine cancer	0.000143	0.00564	CcSEcCtD
Spironolactone—Drospirenone—PGR—uterine cancer	0.000142	0.103	CrCbGaD
Spironolactone—Ill-defined disorder—Progesterone—uterine cancer	0.000138	0.00544	CcSEcCtD
Spironolactone—CYP2C8—renal system—uterine cancer	0.000137	0.00729	CbGeAlD
Spironolactone—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.000136	0.0054	CcSEcCtD
Spironolactone—AR—female reproductive system—uterine cancer	0.000136	0.00722	CbGeAlD
Spironolactone—Malaise—Progesterone—uterine cancer	0.000134	0.00529	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Dactinomycin—uterine cancer	0.000133	0.00526	CcSEcCtD
Spironolactone—CYP2C8—endometrium—uterine cancer	0.000133	0.00705	CbGeAlD
Spironolactone—NR3C1—epithelium—uterine cancer	0.000132	0.00704	CbGeAlD
Spironolactone—NR3C1—uterine cervix—uterine cancer	0.000131	0.00698	CbGeAlD
Spironolactone—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.000129	0.00511	CcSEcCtD
Spironolactone—NR3C1—smooth muscle tissue—uterine cancer	0.000128	0.00678	CbGeAlD
Spironolactone—Rash erythematous—Epirubicin—uterine cancer	0.000127	0.00503	CcSEcCtD
Spironolactone—Agranulocytosis—Dactinomycin—uterine cancer	0.000125	0.00495	CcSEcCtD
Spironolactone—NR3C1—decidua—uterine cancer	0.000125	0.00665	CbGeAlD
Spironolactone—Discomfort—Progesterone—uterine cancer	0.000125	0.00494	CcSEcCtD
Spironolactone—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.000125	0.00493	CcSEcCtD
Spironolactone—AR—female gonad—uterine cancer	0.000124	0.00657	CbGeAlD
Spironolactone—AR—vagina—uterine cancer	0.000123	0.00653	CbGeAlD
Spironolactone—NR3C1—renal system—uterine cancer	0.000123	0.00653	CbGeAlD
Spironolactone—Confusional state—Progesterone—uterine cancer	0.000122	0.00483	CcSEcCtD
Spironolactone—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.000121	0.00479	CcSEcCtD
Spironolactone—Anaphylactic shock—Progesterone—uterine cancer	0.000121	0.00479	CcSEcCtD
Spironolactone—NR3C1—endometrium—uterine cancer	0.000119	0.00631	CbGeAlD
Spironolactone—Rash erythematous—Doxorubicin—uterine cancer	0.000118	0.00465	CcSEcCtD
Spironolactone—NR3C1—mammalian vulva—uterine cancer	0.000115	0.0061	CbGeAlD
Spironolactone—Erythema multiforme—Dactinomycin—uterine cancer	0.000114	0.0045	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Etoposide—uterine cancer	0.000113	0.00449	CcSEcCtD
Spironolactone—Cramp muscle—Etoposide—uterine cancer	0.000113	0.00449	CcSEcCtD
Spironolactone—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000113	0.00447	CcSEcCtD
Spironolactone—Breast pain—Epirubicin—uterine cancer	0.000112	0.00441	CcSEcCtD
Spironolactone—Amenorrhoea—Epirubicin—uterine cancer	0.000111	0.00438	CcSEcCtD
Spironolactone—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.000111	0.00438	CcSEcCtD
Spironolactone—CYP2C8—female reproductive system—uterine cancer	0.00011	0.00584	CbGeAlD
Spironolactone—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00011	0.00434	CcSEcCtD
Spironolactone—NR3C1—uterus—uterine cancer	0.000109	0.00581	CbGeAlD
Spironolactone—Somnolence—Progesterone—uterine cancer	0.000108	0.00426	CcSEcCtD
Spironolactone—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000107	0.00425	CcSEcCtD
Spironolactone—NR3C2—lymph node—uterine cancer	0.000107	0.0057	CbGeAlD
Spironolactone—Alopecia—Dactinomycin—uterine cancer	0.000106	0.00421	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Progesterone—uterine cancer	0.000105	0.00413	CcSEcCtD
Spironolactone—Breast pain—Doxorubicin—uterine cancer	0.000103	0.00408	CcSEcCtD
Spironolactone—Ulcer—Epirubicin—uterine cancer	0.000103	0.00407	CcSEcCtD
Spironolactone—Amenorrhoea—Doxorubicin—uterine cancer	0.000102	0.00405	CcSEcCtD
Spironolactone—Feeling abnormal—Progesterone—uterine cancer	9.98e-05	0.00395	CcSEcCtD
Spironolactone—PGR—lymph node—uterine cancer	9.97e-05	0.0053	CbGeAlD
Spironolactone—CYP2C8—vagina—uterine cancer	9.94e-05	0.00528	CbGeAlD
Spironolactone—NR3C1—female reproductive system—uterine cancer	9.84e-05	0.00523	CbGeAlD
Spironolactone—Somnolence—Medroxyprogesterone Acetate—uterine cancer	9.75e-05	0.00386	CcSEcCtD
Spironolactone—Ill-defined disorder—Dactinomycin—uterine cancer	9.73e-05	0.00385	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Etoposide—uterine cancer	9.63e-05	0.00381	CcSEcCtD
Spironolactone—Urticaria—Progesterone—uterine cancer	9.62e-05	0.0038	CcSEcCtD
Spironolactone—Body temperature increased—Progesterone—uterine cancer	9.57e-05	0.00379	CcSEcCtD
Spironolactone—Hyperkalaemia—Epirubicin—uterine cancer	9.56e-05	0.00378	CcSEcCtD
Spironolactone—Renal failure—Etoposide—uterine cancer	9.55e-05	0.00378	CcSEcCtD
Spironolactone—Ulcer—Doxorubicin—uterine cancer	9.52e-05	0.00376	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	9.47e-05	0.00375	CcSEcCtD
Spironolactone—Malaise—Dactinomycin—uterine cancer	9.45e-05	0.00374	CcSEcCtD
Spironolactone—Medroxyprogesterone Acetate—PGR—uterine cancer	9.45e-05	0.0689	CrCbGaD
Spironolactone—Leukopenia—Dactinomycin—uterine cancer	9.39e-05	0.00371	CcSEcCtD
Spironolactone—Agranulocytosis—Etoposide—uterine cancer	9.06e-05	0.00358	CcSEcCtD
Spironolactone—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	9.04e-05	0.00358	CcSEcCtD
Spironolactone—ABCB1—myometrium—uterine cancer	9.03e-05	0.0048	CbGeAlD
Spironolactone—NR3C1—female gonad—uterine cancer	8.95e-05	0.00476	CbGeAlD
Spironolactone—Cramps of lower extremities—Epirubicin—uterine cancer	8.94e-05	0.00354	CcSEcCtD
Spironolactone—Hypersensitivity—Progesterone—uterine cancer	8.92e-05	0.00353	CcSEcCtD
Spironolactone—NR3C1—vagina—uterine cancer	8.9e-05	0.00473	CbGeAlD
Spironolactone—Hyperkalaemia—Doxorubicin—uterine cancer	8.85e-05	0.0035	CcSEcCtD
Spironolactone—Discomfort—Dactinomycin—uterine cancer	8.82e-05	0.00349	CcSEcCtD
Spironolactone—Urticaria—Medroxyprogesterone Acetate—uterine cancer	8.72e-05	0.00345	CcSEcCtD
Spironolactone—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	8.67e-05	0.00343	CcSEcCtD
Spironolactone—ABCC2—lymph node—uterine cancer	8.57e-05	0.00455	CbGeAlD
Spironolactone—Pruritus—Progesterone—uterine cancer	8.57e-05	0.00339	CcSEcCtD
Spironolactone—Thrombocytopenia—Dactinomycin—uterine cancer	8.38e-05	0.00331	CcSEcCtD
Spironolactone—Diarrhoea—Progesterone—uterine cancer	8.28e-05	0.00328	CcSEcCtD
Spironolactone—Cramps of lower extremities—Doxorubicin—uterine cancer	8.27e-05	0.00327	CcSEcCtD
Spironolactone—Erythema multiforme—Etoposide—uterine cancer	8.24e-05	0.00326	CcSEcCtD
Spironolactone—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	8.08e-05	0.0032	CcSEcCtD
Spironolactone—Dizziness—Progesterone—uterine cancer	8.01e-05	0.00317	CcSEcCtD
Spironolactone—AR—lymph node—uterine cancer	7.95e-05	0.00422	CbGeAlD
Spironolactone—Pruritus—Medroxyprogesterone Acetate—uterine cancer	7.76e-05	0.00307	CcSEcCtD
Spironolactone—Alopecia—Etoposide—uterine cancer	7.7e-05	0.00305	CcSEcCtD
Spironolactone—Vomiting—Progesterone—uterine cancer	7.7e-05	0.00304	CcSEcCtD
Spironolactone—Renal failure acute—Epirubicin—uterine cancer	7.65e-05	0.00303	CcSEcCtD
Spironolactone—Rash—Progesterone—uterine cancer	7.63e-05	0.00302	CcSEcCtD
Spironolactone—Dermatitis—Progesterone—uterine cancer	7.63e-05	0.00302	CcSEcCtD
Spironolactone—Headache—Progesterone—uterine cancer	7.58e-05	0.003	CcSEcCtD
Spironolactone—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	7.51e-05	0.00297	CcSEcCtD
Spironolactone—Muscle spasms—Etoposide—uterine cancer	7.3e-05	0.00289	CcSEcCtD
Spironolactone—Dizziness—Medroxyprogesterone Acetate—uterine cancer	7.25e-05	0.00287	CcSEcCtD
Spironolactone—Lethargy—Epirubicin—uterine cancer	7.21e-05	0.00285	CcSEcCtD
Spironolactone—Nausea—Progesterone—uterine cancer	7.19e-05	0.00284	CcSEcCtD
Spironolactone—ABCB1—epithelium—uterine cancer	7.09e-05	0.00377	CbGeAlD
Spironolactone—Renal failure acute—Doxorubicin—uterine cancer	7.08e-05	0.0028	CcSEcCtD
Spironolactone—Feeling abnormal—Dactinomycin—uterine cancer	7.05e-05	0.00279	CcSEcCtD
Spironolactone—Ill-defined disorder—Etoposide—uterine cancer	7.04e-05	0.00278	CcSEcCtD
Spironolactone—ABCB1—uterine cervix—uterine cancer	7.03e-05	0.00373	CbGeAlD
Spironolactone—Vomiting—Medroxyprogesterone Acetate—uterine cancer	6.98e-05	0.00276	CcSEcCtD
Spironolactone—Fluoxymesterone—ESR1—uterine cancer	6.95e-05	0.0507	CrCbGaD
Spironolactone—Rash—Medroxyprogesterone Acetate—uterine cancer	6.92e-05	0.00274	CcSEcCtD
Spironolactone—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	6.91e-05	0.00273	CcSEcCtD
Spironolactone—Headache—Medroxyprogesterone Acetate—uterine cancer	6.87e-05	0.00272	CcSEcCtD
Spironolactone—Malaise—Etoposide—uterine cancer	6.84e-05	0.00271	CcSEcCtD
Spironolactone—Testosterone—CYP11A1—uterine cancer	6.84e-05	0.0499	CrCbGaD
Spironolactone—Leukopenia—Etoposide—uterine cancer	6.79e-05	0.00269	CcSEcCtD
Spironolactone—Body temperature increased—Dactinomycin—uterine cancer	6.76e-05	0.00268	CcSEcCtD
Spironolactone—ABCB1—decidua—uterine cancer	6.7e-05	0.00356	CbGeAlD
Spironolactone—Lethargy—Doxorubicin—uterine cancer	6.67e-05	0.00264	CcSEcCtD
Spironolactone—Ataxia—Epirubicin—uterine cancer	6.64e-05	0.00263	CcSEcCtD
Spironolactone—ABCB1—renal system—uterine cancer	6.58e-05	0.00349	CbGeAlD
Spironolactone—Nausea—Medroxyprogesterone Acetate—uterine cancer	6.52e-05	0.00258	CcSEcCtD
Spironolactone—Discomfort—Etoposide—uterine cancer	6.38e-05	0.00252	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Epirubicin—uterine cancer	6.36e-05	0.00252	CcSEcCtD
Spironolactone—ABCB1—endometrium—uterine cancer	6.36e-05	0.00338	CbGeAlD
Spironolactone—Hypersensitivity—Dactinomycin—uterine cancer	6.3e-05	0.00249	CcSEcCtD
Spironolactone—Gastritis—Epirubicin—uterine cancer	6.25e-05	0.00247	CcSEcCtD
Spironolactone—Confusional state—Etoposide—uterine cancer	6.24e-05	0.00247	CcSEcCtD
Spironolactone—Anaphylactic shock—Etoposide—uterine cancer	6.19e-05	0.00245	CcSEcCtD
Spironolactone—ABCB1—mammalian vulva—uterine cancer	6.15e-05	0.00327	CbGeAlD
Spironolactone—Ataxia—Doxorubicin—uterine cancer	6.15e-05	0.00243	CcSEcCtD
Spironolactone—Methyltestosterone—CYP19A1—uterine cancer	6.1e-05	0.0445	CrCbGaD
Spironolactone—Thrombocytopenia—Etoposide—uterine cancer	6.06e-05	0.0024	CcSEcCtD
Spironolactone—Eosinophilia—Epirubicin—uterine cancer	6.04e-05	0.00239	CcSEcCtD
Spironolactone—Medroxyprogesterone Acetate—ESR1—uterine cancer	5.96e-05	0.0435	CrCbGaD
Spironolactone—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	5.89e-05	0.00233	CcSEcCtD
Spironolactone—ABCB1—uterus—uterine cancer	5.86e-05	0.00311	CbGeAlD
Spironolactone—Diarrhoea—Dactinomycin—uterine cancer	5.85e-05	0.00232	CcSEcCtD
Spironolactone—Gastritis—Doxorubicin—uterine cancer	5.78e-05	0.00229	CcSEcCtD
Spironolactone—NR3C1—lymph node—uterine cancer	5.76e-05	0.00306	CbGeAlD
Spironolactone—Eosinophilia—Doxorubicin—uterine cancer	5.59e-05	0.00221	CcSEcCtD
Spironolactone—Somnolence—Etoposide—uterine cancer	5.51e-05	0.00218	CcSEcCtD
Spironolactone—Progesterone—PGR—uterine cancer	5.46e-05	0.0398	CrCbGaD
Spironolactone—Drowsiness—Epirubicin—uterine cancer	5.44e-05	0.00215	CcSEcCtD
Spironolactone—Vomiting—Dactinomycin—uterine cancer	5.44e-05	0.00215	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Epirubicin—uterine cancer	5.4e-05	0.00213	CcSEcCtD
Spironolactone—Rash—Dactinomycin—uterine cancer	5.4e-05	0.00213	CcSEcCtD
Spironolactone—Renal failure—Epirubicin—uterine cancer	5.35e-05	0.00212	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Etoposide—uterine cancer	5.35e-05	0.00211	CcSEcCtD
Spironolactone—ABCB1—female reproductive system—uterine cancer	5.27e-05	0.0028	CbGeAlD
Spironolactone—Feeling abnormal—Etoposide—uterine cancer	5.1e-05	0.00202	CcSEcCtD
Spironolactone—Nausea—Dactinomycin—uterine cancer	5.08e-05	0.00201	CcSEcCtD
Spironolactone—Agranulocytosis—Epirubicin—uterine cancer	5.08e-05	0.00201	CcSEcCtD
Spironolactone—Drowsiness—Doxorubicin—uterine cancer	5.04e-05	0.00199	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	4.99e-05	0.00197	CcSEcCtD
Spironolactone—Renal failure—Doxorubicin—uterine cancer	4.95e-05	0.00196	CcSEcCtD
Spironolactone—Urticaria—Etoposide—uterine cancer	4.92e-05	0.00195	CcSEcCtD
Spironolactone—Body temperature increased—Etoposide—uterine cancer	4.9e-05	0.00194	CcSEcCtD
Spironolactone—ABCB1—female gonad—uterine cancer	4.79e-05	0.00255	CbGeAlD
Spironolactone—ABCB1—vagina—uterine cancer	4.76e-05	0.00253	CbGeAlD
Spironolactone—Agranulocytosis—Doxorubicin—uterine cancer	4.7e-05	0.00186	CcSEcCtD
Spironolactone—Erythema multiforme—Epirubicin—uterine cancer	4.62e-05	0.00183	CcSEcCtD
Spironolactone—Hypersensitivity—Etoposide—uterine cancer	4.56e-05	0.0018	CcSEcCtD
Spironolactone—Pruritus—Etoposide—uterine cancer	4.38e-05	0.00173	CcSEcCtD
Spironolactone—Alopecia—Epirubicin—uterine cancer	4.32e-05	0.00171	CcSEcCtD
Spironolactone—Erythema multiforme—Doxorubicin—uterine cancer	4.27e-05	0.00169	CcSEcCtD
Spironolactone—Diarrhoea—Etoposide—uterine cancer	4.24e-05	0.00168	CcSEcCtD
Spironolactone—Dizziness—Etoposide—uterine cancer	4.1e-05	0.00162	CcSEcCtD
Spironolactone—Muscle spasms—Epirubicin—uterine cancer	4.09e-05	0.00162	CcSEcCtD
Spironolactone—Alopecia—Doxorubicin—uterine cancer	4e-05	0.00158	CcSEcCtD
Spironolactone—Ill-defined disorder—Epirubicin—uterine cancer	3.95e-05	0.00156	CcSEcCtD
Spironolactone—Vomiting—Etoposide—uterine cancer	3.94e-05	0.00156	CcSEcCtD
Spironolactone—Rash—Etoposide—uterine cancer	3.9e-05	0.00154	CcSEcCtD
Spironolactone—Dermatitis—Etoposide—uterine cancer	3.9e-05	0.00154	CcSEcCtD
Spironolactone—Headache—Etoposide—uterine cancer	3.88e-05	0.00153	CcSEcCtD
Spironolactone—Malaise—Epirubicin—uterine cancer	3.84e-05	0.00152	CcSEcCtD
Spironolactone—Leukopenia—Epirubicin—uterine cancer	3.81e-05	0.00151	CcSEcCtD
Spironolactone—Muscle spasms—Doxorubicin—uterine cancer	3.78e-05	0.0015	CcSEcCtD
Spironolactone—Nausea—Etoposide—uterine cancer	3.68e-05	0.00145	CcSEcCtD
Spironolactone—Ill-defined disorder—Doxorubicin—uterine cancer	3.65e-05	0.00144	CcSEcCtD
Spironolactone—Discomfort—Epirubicin—uterine cancer	3.58e-05	0.00142	CcSEcCtD
Spironolactone—Malaise—Doxorubicin—uterine cancer	3.55e-05	0.0014	CcSEcCtD
Spironolactone—Testosterone—CYP19A1—uterine cancer	3.54e-05	0.0258	CrCbGaD
Spironolactone—Leukopenia—Doxorubicin—uterine cancer	3.52e-05	0.00139	CcSEcCtD
Spironolactone—Confusional state—Epirubicin—uterine cancer	3.5e-05	0.00138	CcSEcCtD
Spironolactone—Anaphylactic shock—Epirubicin—uterine cancer	3.47e-05	0.00137	CcSEcCtD
Spironolactone—Progesterone—ESR1—uterine cancer	3.44e-05	0.0251	CrCbGaD
Spironolactone—Thrombocytopenia—Epirubicin—uterine cancer	3.4e-05	0.00134	CcSEcCtD
Spironolactone—Discomfort—Doxorubicin—uterine cancer	3.31e-05	0.00131	CcSEcCtD
Spironolactone—Confusional state—Doxorubicin—uterine cancer	3.24e-05	0.00128	CcSEcCtD
Spironolactone—Anaphylactic shock—Doxorubicin—uterine cancer	3.21e-05	0.00127	CcSEcCtD
Spironolactone—Thrombocytopenia—Doxorubicin—uterine cancer	3.15e-05	0.00124	CcSEcCtD
Spironolactone—Somnolence—Epirubicin—uterine cancer	3.09e-05	0.00122	CcSEcCtD
Spironolactone—ABCB1—lymph node—uterine cancer	3.08e-05	0.00164	CbGeAlD
Spironolactone—Gastrointestinal disorder—Epirubicin—uterine cancer	3e-05	0.00119	CcSEcCtD
Spironolactone—Feeling abnormal—Epirubicin—uterine cancer	2.86e-05	0.00113	CcSEcCtD
Spironolactone—Somnolence—Doxorubicin—uterine cancer	2.86e-05	0.00113	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Doxorubicin—uterine cancer	2.77e-05	0.0011	CcSEcCtD
Spironolactone—Urticaria—Epirubicin—uterine cancer	2.76e-05	0.00109	CcSEcCtD
Spironolactone—Body temperature increased—Epirubicin—uterine cancer	2.74e-05	0.00109	CcSEcCtD
Spironolactone—Feeling abnormal—Doxorubicin—uterine cancer	2.65e-05	0.00105	CcSEcCtD
Spironolactone—Hypersensitivity—Epirubicin—uterine cancer	2.56e-05	0.00101	CcSEcCtD
Spironolactone—Urticaria—Doxorubicin—uterine cancer	2.55e-05	0.00101	CcSEcCtD
Spironolactone—Body temperature increased—Doxorubicin—uterine cancer	2.54e-05	0.001	CcSEcCtD
Spironolactone—Pruritus—Epirubicin—uterine cancer	2.46e-05	0.000971	CcSEcCtD
Spironolactone—Diarrhoea—Epirubicin—uterine cancer	2.38e-05	0.000939	CcSEcCtD
Spironolactone—Hypersensitivity—Doxorubicin—uterine cancer	2.37e-05	0.000936	CcSEcCtD
Spironolactone—Dizziness—Epirubicin—uterine cancer	2.3e-05	0.000908	CcSEcCtD
Spironolactone—Pruritus—Doxorubicin—uterine cancer	2.27e-05	0.000899	CcSEcCtD
Spironolactone—Vomiting—Epirubicin—uterine cancer	2.21e-05	0.000873	CcSEcCtD
Spironolactone—Diarrhoea—Doxorubicin—uterine cancer	2.2e-05	0.000869	CcSEcCtD
Spironolactone—Rash—Epirubicin—uterine cancer	2.19e-05	0.000866	CcSEcCtD
Spironolactone—Dermatitis—Epirubicin—uterine cancer	2.19e-05	0.000865	CcSEcCtD
Spironolactone—Headache—Epirubicin—uterine cancer	2.17e-05	0.00086	CcSEcCtD
Spironolactone—Dizziness—Doxorubicin—uterine cancer	2.12e-05	0.00084	CcSEcCtD
Spironolactone—Nausea—Epirubicin—uterine cancer	2.06e-05	0.000816	CcSEcCtD
Spironolactone—Vomiting—Doxorubicin—uterine cancer	2.04e-05	0.000808	CcSEcCtD
Spironolactone—Rash—Doxorubicin—uterine cancer	2.03e-05	0.000801	CcSEcCtD
Spironolactone—NR3C1—AP-1 transcription factor network—PTEN—uterine cancer	2.02e-05	0.00101	CbGpPWpGaD
Spironolactone—Dermatitis—Doxorubicin—uterine cancer	2.02e-05	0.0008	CcSEcCtD
Spironolactone—Headache—Doxorubicin—uterine cancer	2.01e-05	0.000796	CcSEcCtD
Spironolactone—AR—Integrated Breast Cancer Pathway—CDH1—uterine cancer	2.01e-05	0.000999	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—uterine cancer	1.98e-05	0.000988	CbGpPWpGaD
Spironolactone—CYP2C8—Biological oxidations—CYP11A1—uterine cancer	1.98e-05	0.000985	CbGpPWpGaD
Spironolactone—CYP2C8—Metapathway biotransformation—CYP11A1—uterine cancer	1.95e-05	0.000972	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—EP300—uterine cancer	1.93e-05	0.000962	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	1.91e-05	0.000952	CbGpPWpGaD
Spironolactone—Nausea—Doxorubicin—uterine cancer	1.91e-05	0.000755	CcSEcCtD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.9e-05	0.000944	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—PTEN—uterine cancer	1.88e-05	0.000938	CbGpPWpGaD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—AKT1—uterine cancer	1.88e-05	0.000935	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—PGR—uterine cancer	1.84e-05	0.000919	CbGpPWpGaD
Spironolactone—CYP2C8—Metapathway biotransformation—AKR1C3—uterine cancer	1.84e-05	0.000918	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—AKR1B1—uterine cancer	1.83e-05	0.000914	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—STAR—uterine cancer	1.83e-05	0.000914	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PHF1—uterine cancer	1.83e-05	0.000911	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.81e-05	0.000903	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—PGR—uterine cancer	1.78e-05	0.000885	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	1.76e-05	0.000875	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—EZH2—uterine cancer	1.75e-05	0.000872	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—uterine cancer	1.72e-05	0.000856	CbGpPWpGaD
Spironolactone—AR—Gene Expression—SUZ12—uterine cancer	1.72e-05	0.000856	CbGpPWpGaD
Spironolactone—AR—Coregulation of Androgen receptor activity—AKT1—uterine cancer	1.72e-05	0.000855	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—EP300—uterine cancer	1.7e-05	0.000848	CbGpPWpGaD
Spironolactone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	1.69e-05	0.000843	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—NRAS—uterine cancer	1.68e-05	0.000837	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—CDKN2B—uterine cancer	1.67e-05	0.000833	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—POLD1—uterine cancer	1.67e-05	0.000832	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—ESR2—uterine cancer	1.62e-05	0.000809	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—NDUFB11—uterine cancer	1.59e-05	0.000793	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—SRD5A2—uterine cancer	1.59e-05	0.000793	CbGpPWpGaD
Spironolactone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	1.57e-05	0.000783	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—ESR2—uterine cancer	1.56e-05	0.000779	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—CXCL8—uterine cancer	1.56e-05	0.000779	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—AKR1C1—uterine cancer	1.56e-05	0.000778	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—CHD4—uterine cancer	1.56e-05	0.000775	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.55e-05	0.00077	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—SMAD3—uterine cancer	1.53e-05	0.00076	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	1.48e-05	0.000737	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.46e-05	0.000727	CbGpPWpGaD
Spironolactone—CYP2C8—Biological oxidations—CYP19A1—uterine cancer	1.45e-05	0.000725	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—KRAS—uterine cancer	1.45e-05	0.000721	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—PTEN—uterine cancer	1.44e-05	0.000719	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	1.44e-05	0.000718	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—POLD1—uterine cancer	1.44e-05	0.000717	CbGpPWpGaD
Spironolactone—CYP2C8—Metapathway biotransformation—CYP19A1—uterine cancer	1.43e-05	0.000715	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AKR1B10—uterine cancer	1.43e-05	0.000711	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.4e-05	0.000698	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—RRM2—uterine cancer	1.39e-05	0.000694	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	1.38e-05	0.00069	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—TP53—uterine cancer	1.38e-05	0.000688	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—EP300—uterine cancer	1.38e-05	0.000685	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	1.37e-05	0.000682	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—DCN—uterine cancer	1.35e-05	0.000674	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—PGR—uterine cancer	1.35e-05	0.000672	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—AKR1C1—uterine cancer	1.35e-05	0.000671	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—EP300—uterine cancer	1.34e-05	0.000668	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—PIK3CA—uterine cancer	1.33e-05	0.000662	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—CDKN2B—uterine cancer	1.32e-05	0.000658	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—SUZ12—uterine cancer	1.3e-05	0.000649	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	1.3e-05	0.000649	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.3e-05	0.000647	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	1.28e-05	0.000639	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CYP11A1—uterine cancer	1.27e-05	0.000635	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—CDKN2B—uterine cancer	1.27e-05	0.000634	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—VEGFA—uterine cancer	1.27e-05	0.000633	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—AKT1—uterine cancer	1.27e-05	0.000632	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	1.27e-05	0.000632	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—STAR—uterine cancer	1.27e-05	0.000632	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—CTNNB1—uterine cancer	1.27e-05	0.000631	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—ESR1—uterine cancer	1.25e-05	0.00062	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—HRAS—uterine cancer	1.23e-05	0.000613	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.23e-05	0.000611	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—TP53—uterine cancer	1.22e-05	0.000607	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—SMAD3—uterine cancer	1.21e-05	0.000601	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—AKR1C3—uterine cancer	1.2e-05	0.000599	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—RRM2—uterine cancer	1.2e-05	0.000598	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.2e-05	0.000596	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—ESR2—uterine cancer	1.19e-05	0.000591	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—CXCL8—uterine cancer	1.19e-05	0.000591	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—RNF43—uterine cancer	1.18e-05	0.000589	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	1.17e-05	0.000581	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—DCN—uterine cancer	1.17e-05	0.00058	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—SMAD3—uterine cancer	1.16e-05	0.000579	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—AKR1B1—uterine cancer	1.15e-05	0.000573	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—STAR—uterine cancer	1.15e-05	0.000573	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.14e-05	0.000568	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.14e-05	0.000566	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—KRAS—uterine cancer	1.11e-05	0.000552	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—CXCL8—uterine cancer	1.1e-05	0.000547	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CYP11A1—uterine cancer	1.1e-05	0.000547	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	1.09e-05	0.000545	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	1.09e-05	0.000542	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—AKT1—uterine cancer	1.09e-05	0.000541	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—INHBA—uterine cancer	1.08e-05	0.000538	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.08e-05	0.000538	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—EZH2—uterine cancer	1.07e-05	0.000531	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	1.05e-05	0.000524	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	1.04e-05	0.000521	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	1.04e-05	0.000517	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—AKR1C3—uterine cancer	1.04e-05	0.000516	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	1.03e-05	0.000513	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—uterine cancer	1.03e-05	0.000512	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—EP300—uterine cancer	1.02e-05	0.000507	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—ESR2—uterine cancer	9.89e-06	0.000493	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—TP53—uterine cancer	9.85e-06	0.000491	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—ESR1—uterine cancer	9.85e-06	0.00049	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AKR1C1—uterine cancer	9.73e-06	0.000485	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—CDKN2B—uterine cancer	9.66e-06	0.000481	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—VEGFA—uterine cancer	9.63e-06	0.00048	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—ESR1—uterine cancer	9.49e-06	0.000473	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—STK11—uterine cancer	9.37e-06	0.000467	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CYP19A1—uterine cancer	9.37e-06	0.000467	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	9.32e-06	0.000464	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	9.18e-06	0.000457	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—POLD1—uterine cancer	9.03e-06	0.00045	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—VEGFA—uterine cancer	8.92e-06	0.000444	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—SMAD3—uterine cancer	8.82e-06	0.000439	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.8e-06	0.000438	CbGpPWpGaD
Spironolactone—AR—Gene Expression—PGR—uterine cancer	8.56e-06	0.000426	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—AKR1C1—uterine cancer	8.44e-06	0.000421	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	8.43e-06	0.00042	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.39e-06	0.000418	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—AKT1—uterine cancer	8.32e-06	0.000414	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	8.16e-06	0.000406	CbGpPWpGaD
Spironolactone—AR—Gene Expression—EZH2—uterine cancer	8.13e-06	0.000405	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—STK11—uterine cancer	8.08e-06	0.000402	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CYP19A1—uterine cancer	8.08e-06	0.000402	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—CDKN2B—uterine cancer	8.05e-06	0.000401	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SRD5A2—uterine cancer	7.82e-06	0.000389	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NDUFB11—uterine cancer	7.82e-06	0.000389	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	7.79e-06	0.000388	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	7.59e-06	0.000378	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.58e-06	0.000378	CbGpPWpGaD
Spironolactone—AR—Gene Expression—ESR2—uterine cancer	7.53e-06	0.000375	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—RRM2—uterine cancer	7.53e-06	0.000375	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AKR1C3—uterine cancer	7.49e-06	0.000373	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—SMAD3—uterine cancer	7.35e-06	0.000366	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—DCN—uterine cancer	7.31e-06	0.000364	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.23e-06	0.00036	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—ESR1—uterine cancer	7.2e-06	0.000359	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	7.17e-06	0.000357	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—MTHFR—uterine cancer	7.04e-06	0.000351	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—YWHAE—uterine cancer	6.97e-06	0.000347	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	6.89e-06	0.000343	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CYP11A1—uterine cancer	6.88e-06	0.000343	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NDUFB11—uterine cancer	6.81e-06	0.000339	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SRD5A2—uterine cancer	6.81e-06	0.000339	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—FBXW7—uterine cancer	6.68e-06	0.000333	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	6.57e-06	0.000327	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—AKR1C3—uterine cancer	6.5e-06	0.000324	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PGR—uterine cancer	6.49e-06	0.000323	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.21e-06	0.000309	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—EZH2—uterine cancer	6.17e-06	0.000307	CbGpPWpGaD
Spironolactone—AR—Gene Expression—CDKN2B—uterine cancer	6.13e-06	0.000305	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—MTHFR—uterine cancer	6.07e-06	0.000302	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—ESR1—uterine cancer	6e-06	0.000299	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—STK11—uterine cancer	5.84e-06	0.000291	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—ESR2—uterine cancer	5.71e-06	0.000285	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	5.71e-06	0.000285	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—AKR1B1—uterine cancer	5.65e-06	0.000282	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—STAR—uterine cancer	5.65e-06	0.000282	CbGpPWpGaD
Spironolactone—AR—Gene Expression—SMAD3—uterine cancer	5.6e-06	0.000279	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.59e-06	0.000278	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SOCS3—uterine cancer	5.47e-06	0.000272	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.35e-06	0.000266	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	5.29e-06	0.000264	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CDKN2B—uterine cancer	5.23e-06	0.000261	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IGF1R—uterine cancer	5.08e-06	0.000253	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—STK11—uterine cancer	5.06e-06	0.000252	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CYP19A1—uterine cancer	5.06e-06	0.000252	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	5e-06	0.000249	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—AKR1B1—uterine cancer	4.92e-06	0.000245	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—STAR—uterine cancer	4.92e-06	0.000245	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	4.87e-06	0.000243	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SMAD3—uterine cancer	4.78e-06	0.000238	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.75e-06	0.000237	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—CDKN2B—uterine cancer	4.65e-06	0.000232	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	4.65e-06	0.000232	CbGpPWpGaD
Spironolactone—AR—Gene Expression—ESR1—uterine cancer	4.57e-06	0.000228	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—FGFR2—uterine cancer	4.56e-06	0.000227	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.53e-06	0.000226	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—POLD1—uterine cancer	4.44e-06	0.000221	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	4.4e-06	0.000219	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—SMAD3—uterine cancer	4.25e-06	0.000212	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—AKR1C1—uterine cancer	4.15e-06	0.000207	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PTEN—uterine cancer	3.92e-06	0.000195	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ESR1—uterine cancer	3.9e-06	0.000194	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—POLD1—uterine cancer	3.86e-06	0.000192	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—MTHFR—uterine cancer	3.81e-06	0.00019	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	3.74e-06	0.000186	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—EP300—uterine cancer	3.74e-06	0.000186	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—RRM2—uterine cancer	3.7e-06	0.000184	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—AKR1C1—uterine cancer	3.61e-06	0.00018	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—DCN—uterine cancer	3.59e-06	0.000179	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—AKT1—uterine cancer	3.55e-06	0.000177	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—ESR1—uterine cancer	3.47e-06	0.000173	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	3.44e-06	0.000171	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCL2—uterine cancer	3.43e-06	0.000171	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP11A1—uterine cancer	3.38e-06	0.000168	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTEN—uterine cancer	3.38e-06	0.000168	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.35e-06	0.000167	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	3.33e-06	0.000166	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—RRM2—uterine cancer	3.22e-06	0.00016	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—EP300—uterine cancer	3.22e-06	0.00016	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—AKR1C3—uterine cancer	3.19e-06	0.000159	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—DCN—uterine cancer	3.13e-06	0.000156	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP11A1—uterine cancer	2.95e-06	0.000147	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ERBB2—uterine cancer	2.86e-06	0.000143	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	2.81e-06	0.00014	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—AKR1C3—uterine cancer	2.78e-06	0.000139	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PIK3CA—uterine cancer	2.76e-06	0.000138	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CXCL8—uterine cancer	2.71e-06	0.000135	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CDKN1B—uterine cancer	2.65e-06	0.000132	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CTNNB1—uterine cancer	2.5e-06	0.000125	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—STK11—uterine cancer	2.49e-06	0.000124	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP19A1—uterine cancer	2.49e-06	0.000124	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PTEN—uterine cancer	2.44e-06	0.000122	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CA—uterine cancer	2.38e-06	0.000119	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.34e-06	0.000116	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EP300—uterine cancer	2.33e-06	0.000116	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—AKT1—uterine cancer	2.26e-06	0.000112	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.23e-06	0.000111	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—VEGFA—uterine cancer	2.2e-06	0.00011	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NRAS—uterine cancer	2.18e-06	0.000108	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP19A1—uterine cancer	2.17e-06	0.000108	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—STK11—uterine cancer	2.17e-06	0.000108	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—AKT1—uterine cancer	2.16e-06	0.000108	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTEN—uterine cancer	2.12e-06	0.000105	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—EP300—uterine cancer	2.02e-06	0.000101	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—AKT1—uterine cancer	1.95e-06	9.69e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KRAS—uterine cancer	1.87e-06	9.33e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—MTHFR—uterine cancer	1.87e-06	9.31e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CA—uterine cancer	1.72e-06	8.58e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TP53—uterine cancer	1.67e-06	8.3e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—AKT1—uterine cancer	1.65e-06	8.21e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.65e-06	8.21e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—MTHFR—uterine cancer	1.63e-06	8.11e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HRAS—uterine cancer	1.59e-06	7.93e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CA—uterine cancer	1.49e-06	7.44e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AKT1—uterine cancer	1.41e-06	7.01e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—AKT1—uterine cancer	1.25e-06	6.23e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—AKT1—uterine cancer	1.22e-06	6.08e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTEN—uterine cancer	1.04e-06	5.18e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—EP300—uterine cancer	9.92e-07	4.94e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTEN—uterine cancer	9.06e-07	4.51e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—EP300—uterine cancer	8.64e-07	4.31e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CA—uterine cancer	7.34e-07	3.66e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CA—uterine cancer	6.39e-07	3.18e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—AKT1—uterine cancer	5.99e-07	2.99e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—AKT1—uterine cancer	5.22e-07	2.6e-05	CbGpPWpGaD
